0001209191-22-010405.txt : 20220216
0001209191-22-010405.hdr.sgml : 20220216
20220216201203
ACCESSION NUMBER: 0001209191-22-010405
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lockshin Curtis
CENTRAL INDEX KEY: 0001383556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 22645300
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BOULEVARD
STREET 2: SUITE 950
CITY: MIAMI
STATE: FL
ZIP: 33137
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-15
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001383556
Lockshin Curtis
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
0
0
0
Common stock, $0.0001 par value
2022-02-15
4
A
0
10000
0.00
A
20366
D
Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
Includes shares of common stock underlying unvested restricted stock units.
Caitlin Kontulis, attorney-in-fact
2022-02-16